These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 33996587)

  • 1. Radiation Recall Pneumonitis After Treatment With Checkpoint Blockade Immunotherapy: A Case Series and Review of Literature.
    Riviere P; Sumner W; Cornell M; Sandhu A; Murphy JD; Hattangadi-Gluth J; Bruggeman A; Kim SS; Randall JM; Sharabi AB
    Front Oncol; 2021; 11():662954. PubMed ID: 33996587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiation Recall Pneumonitis Anticipates Bilateral Immune-Induced Pneumonitis in Non-Small Cell Lung Cancer.
    Torresan S; Zussino G; Cortiula F; Follador A; Fasola G; Girometti R; Cereser L
    J Clin Med; 2023 Feb; 12(4):. PubMed ID: 36835802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiation recall pneumonitis triggered by an immune checkpoint inhibitor following re-irradiation in a lung cancer patient: a case report.
    Ye X; Yang J; Stebbing J; Peng L
    BMC Pulm Med; 2022 Feb; 22(1):54. PubMed ID: 35123465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiation Recall Pneumonitis Induced by Anti-PD-1 Blockade: A Case Report and Review of the Literature.
    Chen Y; Huang Z; Xing L; Meng X; Yu J
    Front Oncol; 2020; 10():561. PubMed ID: 32411597
    [No Abstract]   [Full Text] [Related]  

  • 5. Radiation recall pneumonitis from immune checkpoint inhibitors after extra pulmonary radiation.
    Kao LE; Stover D
    Respirol Case Rep; 2023 Oct; 11(10):e01223. PubMed ID: 37731586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence, risk factors, and CT characteristics of radiation recall pneumonitis induced by immune checkpoint inhibitor in lung cancer.
    Cousin F; Desir C; Ben Mustapha S; Mievis C; Coucke P; Hustinx R
    Radiother Oncol; 2021 Apr; 157():47-55. PubMed ID: 33453313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiation recall pneumonitis in the setting of immunotherapy and radiation: a focused review.
    McGovern K; Ghaly M; Esposito M; Barnaby K; Seetharamu N
    Future Sci OA; 2019 Jun; 5(5):FSO378. PubMed ID: 31245041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid Development of Clinically Symptomatic Radiation Recall Pneumonitis Immediately Following COVID-19 Vaccination.
    Steber CR; Ponnatapura J; Hughes RT; Farris MK
    Cureus; 2021 Apr; 13(4):e14303. PubMed ID: 33968515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiation recall pneumonitis induced by PD-1/PD-L1 blockades: mechanisms and therapeutic implications.
    Teng F; Li M; Yu J
    BMC Med; 2020 Sep; 18(1):275. PubMed ID: 32943072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive Pneumonitis Profile of Thoracic Radiotherapy Followed by Immune Checkpoint Inhibitor and Risk Factors for Radiation Recall Pneumonitis in Lung Cancer.
    Lu X; Wang J; Zhang T; Zhou Z; Deng L; Wang X; Wang W; Liu W; Tang W; Wang Z; Wang J; Jiang W; Bi N; Wang L
    Front Immunol; 2022; 13():918787. PubMed ID: 35795657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiation recall pneumonitis induced by chemotherapy after thoracic radiotherapy for lung cancer.
    Ding X; Ji W; Li J; Zhang X; Wang L
    Radiat Oncol; 2011 Mar; 6():24. PubMed ID: 21375774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiation Recall Pneumonitis: A Rare Syndrome That Should Be Recognized.
    Jan PR; Chang JW; Wu CE
    Cancers (Basel); 2022 Sep; 14(19):. PubMed ID: 36230564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiation Recall Pneumonitis Induced by Sintilimab: A Case Report and Literature Review.
    Wang M; Xu S; Zhu H
    Front Immunol; 2022; 13():823767. PubMed ID: 35280981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Late-onset programmed cell death protein-1 inhibitor-induced pneumonitis after cessation of nivolumab or pembrolizumab in patients with advanced non-small cell lung cancer: a case series.
    Kimura H; Sone T; Araya T; Murata A; Yamamura K; Ohkura N; Hara J; Abo M; Kasahara K
    Transl Lung Cancer Res; 2021 Mar; 10(3):1576-1581. PubMed ID: 33889531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiation recall pneumonitis induced by epidermal growth factor receptor-tyrosine kinase inhibitor in patients with advanced nonsmall-cell lung cancer.
    Chiang CL; Chen YW; Wu MH; Huang HC; Tsai CM; Chiu CH
    J Chin Med Assoc; 2016 May; 79(5):248-55. PubMed ID: 27036494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiation recall pneumonitis induced by nivolumab in a patient with renal cell carcinoma.
    Nakamura K; Okubo K; Takahashi T; Mitsumori K; Ishigaki T; Ohnishi H
    IJU Case Rep; 2019 Jan; 2(1):30-33. PubMed ID: 32743367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immune-related pneumonitis caused by programmed death-1 inhibitor Pembrolizumab: a case report and literature review].
    Chen YL; Zhao J; Jia R; Wang HY; Zheng J; Bai CQ; Wang MZ; Xu JM
    Zhonghua Jie He He Hu Xi Za Zhi; 2017 Oct; 40(10):736-743. PubMed ID: 29050127
    [No Abstract]   [Full Text] [Related]  

  • 18. Nivolumab-induced radiation recall pneumonitis in non-small-cell lung cancer patients with thoracic radiation therapy.
    Noda-Narita S; Naito T; Udagawa H; Goto K; Miyawaki T; Mamesaya N; Nakashima K; Kenmotsu H; Shimokawaji T; Kato T; Hakozaki T; Okuma Y; Nakamura M; Nakayama Y; Watanabe H; Kusumoto M; Ohe Y; Horinouchi H
    Cancer Sci; 2023 Feb; 114(2):630-639. PubMed ID: 36285515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pituitary immune-related adverse events induced by programmed cell death protein 1 inhibitors in advanced lung cancer patients: A report of 3 cases].
    Gu YC; Liu Y; Xie C; Cao BS
    Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Apr; 54(2):369-375. PubMed ID: 35435206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacovigilance Assessment of Immune-Mediated Reactions Reported for Checkpoint Inhibitor Cancer Immunotherapies.
    Ali AK; Watson DE
    Pharmacotherapy; 2017 Nov; 37(11):1383-1390. PubMed ID: 28950039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.